Firefly Neuroscience, Inc. — Company profile
Technology · Software - Application · United States
Last price 1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 15.69M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
Details
| Name | Firefly Neuroscience, Inc. |
| Sector | Technology |
| Industry | Software - Application |
| Employees | 17 |
| Founded | 2006 |
| Ceo | Greg Lipschitz |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US3179701012 |
| Cusip | 317970101 |
| Cik | 0000803578 |
| Sic | 7372 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Greg Lipschitz | Chief Executive Officer and Director |
| David DeCaprio | President, Chief Operating Officer and Director |
| Gil Issachar | Head of AI and Neuroscience |
| Paul Krzywicki CPA, CGA | Company Secretary |
| Jessica L. Paz | Chief Accounting Officer |
Contact
| Address | 1100 Military Road, Kenmore, New York 14217, United States |
| Phone | 888 237 6412 |
| Website | https://fireflyneuro.com |